FDA kratom

Last Day to Comment on 7-OH Schedule I Placement; Hamilton Morris, Carl Hart Speak Out in Opposition

Tonight at 11:59 PM, the Department of Health and Human Services (HHS) will close comments on the notice “Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information“. The notice asks for specific information and scientific evidence about the threshold of 7-OH that should be allowable in kratom products. However, many …

Last Day to Comment on 7-OH Schedule I Placement; Hamilton Morris, Carl Hart Speak Out in Opposition Read More »

Arizona Kratom Gummy Case Leaves Key Questions Unanswered

A recent case involving a 27-year-old Arizona woman who reportedly suffered heart failure after consuming kratom gummies has drawn national attention. The woman reportedly took the gummies for leg pain and only took them for one week. While the incident has been widely reported, many of the most important details remain unknown. One of the …

Arizona Kratom Gummy Case Leaves Key Questions Unanswered Read More »

DEA Announces Temporary 7-OH Ban; Public Comment Period Underway

On July 6, the United States Drug Enforcement Agency (DEA) published a notice in the Federal Register that it intends to place 7-hydroxymitragynine (7-OH) on Schedule I of the Controlled Substances Act. This is an emergency rule that would temporarily place covered 7-OH products in Schedule I for up to two years while the DEA …

DEA Announces Temporary 7-OH Ban; Public Comment Period Underway Read More »